Jedd Wolchok
MD, PhD
Chief of Melanoma and Immunotherapeutics Service
👥Biography 个人简介
Jedd Wolchok is a global leader in cancer immunotherapy and a pioneer in the development of ipilimumab and nivolumab combination therapy for melanoma. His research has defined primary and acquired resistance mechanisms to immune checkpoint blockade. He led the landmark CheckMate 067 trial demonstrating superior outcomes of combination checkpoint inhibition. His work bridges translational biology with clinical practice in IO resistance.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jedd Wolchok 的研究动态
Follow Jedd Wolchok's research updates
留下邮箱，当我们发布与 Jedd Wolchok（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment